How much revenue did Rxsight generate this year?
Rxsight has achieved a revenue of 142.79 M USD this year.
Rxsight Revenue 2024
Rxsight Revenue
142.79 M USD
Ticker
RXST
ISIN
US78349D1072
In 2024, Rxsight's sales reached 142.79 M USD, a 60.3% difference from the 89.08 M USD sales recorded in the previous year.
The Rxsight Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2028e | 306.71 | 17,53 |
| 2027e | 289.48 | 18,57 |
| 2026e | 240.43 | 22,36 |
| 2025e | 191.79 | 28,03 |
| 2024e | 142.79 | 37,65 |
| 2023 | 89.08 | 60,36 |
| 2022 | 49.01 | 43,52 |
| 2021 | 22.59 | 20,01 |
| 2020 | 14.68 | 11,65 |
| 2019 | 2.24 | -81,25 |
Rxsight Revenue, EBIT, Net Income US78349D1072 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Rxsight, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Rxsight from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Rxsight’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Rxsight. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Rxsight’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Rxsight’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Rxsight’s growth potential.
Rxsight Revenue, EBIT and net profit per share
| Date | Rxsight Revenue | Rxsight EBIT | Rxsight Net Income |
|---|---|---|---|
| 2028e | 306.71 M undefined | -16.12 M undefined | 0 undefined |
| 2027e | 289.48 M undefined | -7.29 M undefined | 50.97 M undefined |
| 2026e | 240.43 M undefined | -12.09 M undefined | -998,464.7 undefined |
| 2025e | 191.79 M undefined | -24.74 M undefined | -15.48 M undefined |
| 2024e | 142.79 M undefined | -37.15 M undefined | -29.66 M undefined |
| 2023 | 89.08 M undefined | -50.09 M undefined | -48.61 M undefined |
| 2022 | 49.01 M undefined | -63.32 M undefined | -66.76 M undefined |
| 2021 | 22.59 M undefined | -52.79 M undefined | -48.69 M undefined |
| 2020 | 14.68 M undefined | -35.4 M undefined | 3.37 M undefined |
| 2019 | 2.24 M undefined | -46.59 M undefined | 26.13 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2019 | 2.24 M USD | -46.59 M USD | 26.13 M USD |
| 2020 | 14.68 M USD | -35.4 M USD | 3.37 M USD |
| 2021 | 22.59 M USD | -52.79 M USD | -48.69 M USD |
| 2022 | 49.01 M USD | -63.32 M USD | -66.76 M USD |
| 2023 | 89.08 M USD | -50.09 M USD | -48.61 M USD |
| 2024e | 142.79 M USD | -37.15 M USD | -29.66 M USD |
| 2025e | 191.79 M USD | -24.74 M USD | -15.48 M USD |
| 2026e | 240.43 M USD | -12.09 M USD | -998,464.7 USD |
| 2027e | 289.48 M USD | -7.29 M USD | 50.97 M USD |
| 2028e | 306.71 M USD | -16.12 M USD | 0 USD |
Rxsight stock margins US78349D1072 ·
The Rxsight margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Rxsight. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Rxsight.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Rxsight's sales revenue. A higher gross margin percentage indicates that the Rxsight retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Rxsight's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Rxsight's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Rxsight's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Rxsight. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Rxsight's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Rxsight Margin History
| Rxsight Gross margin | Rxsight Profit margin | Rxsight EBIT margin | Rxsight Profit margin |
|---|---|---|---|
| 2028e | 60.36 % | -5.25 % | 0 % |
| 2027e | 60.36 % | -2.52 % | 17.61 % |
| 2026e | 60.36 % | -5.03 % | -0.42 % |
| 2025e | 60.36 % | -12.9 % | -8.07 % |
| 2024e | 60.36 % | -26.02 % | -20.77 % |
| 2023 | 60.36 % | -56.23 % | -54.57 % |
| 2022 | 43.52 % | -129.2 % | -136.22 % |
| 2021 | 20.01 % | -233.69 % | -215.54 % |
| 2020 | 11.65 % | -241.14 % | 22.96 % |
| 2019 | -81.25 % | -2,079.91 % | 1,166.52 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2019 | -81.25 % | -2,079.91 % | 1,166.52 % |
| 2020 | 11.65 % | -241.14 % | 22.96 % |
| 2021 | 20.01 % | -233.69 % | -215.54 % |
| 2022 | 43.52 % | -129.2 % | -136.22 % |
| 2023 | 60.36 % | -56.23 % | -54.57 % |
| 2024e | 60.36 % | -26.02 % | -20.77 % |
| 2025e | 60.36 % | -12.9 % | -8.07 % |
| 2026e | 60.36 % | -5.03 % | -0.42 % |
| 2027e | 60.36 % | -2.52 % | 17.61 % |
| 2028e | 60.36 % | -5.25 % | 0 % |
Rxsight Aktienanalyse
What does Rxsight do?
Rxsight Inc is an innovative company that specializes in developing innovative solutions for eye treatments. The company aims to make a positive contribution to the quality of life for patients suffering from eye problems. Rxsight Inc was founded in 2008 by Jim Taylor, who had previously worked in computer graphics at Pixar Animation Studios and was now involved in new technologies for ophthalmology. The business model of Rxsight Inc is based on the development and marketing of medical products that improve the treatment of eye diseases. The company focuses on the field of dynamic ophthalmology, which aims to improve treatment options for eye diseases by focusing on the influence of eye movements and changes in pupil size. Rxsight Inc is divided into various divisions, with an important division focusing on research and development of products that can improve the treatment of eye diseases. The company invests heavily in developing innovative products. Additionally, Rxsight Inc is also involved in the manufacturing and marketing of medical products. Rxsight Inc's products include special contact lenses that can be individually customized through precise measurement of the eye lens. These contact lenses can help patients achieve better visual quality after eye surgery. Rxsight Inc also offers certain measuring devices that are used for measuring and analyzing eye movements and pupil size. Another important product from Rxsight Inc is the "Light Adjustable Lens System," which is a system for intraocular lenses that operates based on feedback from light and energy. The system allows for an individualized process for adjusting the strength of intraocular lenses. With the "Light Adjustable Lens System," patients can achieve significantly improved visual quality after cataract surgery. Overall, Rxsight Inc has established itself as an innovative company in ophthalmology. The company focuses on research and development to provide new technologies for the treatment of eye diseases. Rxsight Inc emphasizes dynamic ophthalmology to consider the influence of eye movements and pupil size in the therapy of eye diseases. With its products, Rxsight Inc makes an important contribution to improving the visual quality of patients. Rxsight ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding Rxsight's Sales Figures
The sales figures of Rxsight originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing Rxsight’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize Rxsight's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in Rxsight’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about Rxsight stock
How much was the turnover of the company Rxsight compared to the previous year?
The revenue of Rxsight has increased by 60.3% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of Rxsight?
The revenue of Rxsight is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of Rxsight measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of Rxsight so important for investors?
The revenue of Rxsight is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does Rxsight pay?
Over the past 12 months, Rxsight paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Rxsight is expected to pay a dividend of 0 USD.
What is the dividend yield of Rxsight?
The current dividend yield of Rxsight is .
When does Rxsight pay dividends?
Rxsight pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Rxsight?
Rxsight paid dividends every year for the past 0 years.
What is the dividend of Rxsight?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Rxsight located?
Rxsight is assigned to the 'Health' sector.
Wann musste ich die Aktien von Rxsight kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Rxsight from 12/25/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/25/2024.
When did Rxsight pay the last dividend?
The last dividend was paid out on 12/25/2024.
What was the dividend of Rxsight in the year 2023?
In the year 2023, Rxsight distributed 0 USD as dividends.
In which currency does Rxsight pay out the dividend?
The dividends of Rxsight are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Rxsight
Our stock analysis for Rxsight Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Rxsight Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.